Two COVID-19 vaccines being tested in the UK have moved on to the third phase of trials, marking a significant step forward in the development process.
One of the vaccines, Novavax, will be tested on around 10,000 participants aged between 18 and 84 over the next four to six weeks.
SUBSCRIBE to our YouTube channel for more videos: [ Ссылка ]
Follow us on Twitter: [ Ссылка ]
Like us on Facebook: [ Ссылка ]
Follow us on Instagram: [ Ссылка ]
For more content go to [ Ссылка ] and download our apps:
Apple: [ Ссылка ]
Android [ Ссылка ]
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí [ Ссылка ]
![](https://i.ytimg.com/vi/CWk8vzZoYN0/maxresdefault.jpg)